TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the ...
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate ...
LONDON, Dec. 16, 2020 /PRNewswire/ -- PrEP Biopharm Limited, a private drug company developing treatments for respiratory infectious diseases, announced that it has successfully completed a 12-week ...
Charles River Laboratories International (CRL) recently reported that its virtual control groups in toxicology studies matched traditional control groups on key outcomes, supporting efforts to reduce ...
COLLEGE STATION, TX / ACCESSWIRE / October 5, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ("ENZC" or the "Company"). The Company announces the completion of the first phase of the animal toxicology ...
Microfluidic chips that mimic human livers are better at predicting whether a drug is toxic to the liver than conventional animal models used in preclinical experimentations, claims a new study from ...
TAMPA, Fla.--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a preclinical stage biopharmaceutical company focused on developing novel products for the treatment of ...
Data from a preclinical chronic toxicology study have torpedoed AbbVie’s psoriasis prospect cedirogant, leading the company to dump the midphase asset and cut off a source of cash for its partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results